Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
DEXTROAMPHETAMINE SACCHARATE
(1996)
Small molecule
Dopamine transporter releasing agent
Unknown
Approved
Attention Deficit Disorder with Hyperactivity; Narcolepsy
DEXTROAMPHETAMINE SACCHARATE
×
Maximum Phase:
4
First Approval:
1996
UNII:
G83415V073
Molecule Type:
Small molecule
Molecular Formula:
C15H23NO8
Molecular Weight:
345.35
AlogP:
1.58
PSA:
26.02
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PHENYLBUTANOIC ACID
(1996)
Small molecule
Unknown
Unknown
Approved
Unknown
PHENYLBUTANOIC ACID
×
Maximum Phase:
4
First Approval:
1996
UNII:
7WY7YBI87E
Molecule Type:
Small molecule
Molecular Formula:
C10H12O2
Molecular Weight:
164.2
AlogP:
2.09
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
4.0
Source:
AZELASTINE HYDROCHLORIDE
(1996)
Small molecule
Histamine H1 receptor antagonist
NASAL; OPHTHALMIC
Approved
Conjunctivitis, Allergic; Nasal Obstruction; Rhinitis, Allergic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Rhinitis, Vasomotor
AZELASTINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
0L591QR10I
Molecule Type:
Small molecule
Molecular Formula:
C22H25Cl2N3O
Molecular Weight:
418.37
AlogP:
4.3
PSA:
38.13
HBD:
0.0
HBA:
#RotB:
3.0
Source:
UREA C 13
(1996)
Small molecule
Unknown
Unknown
Approved
Unknown
UREA C 13
×
Maximum Phase:
4
First Approval:
1996
UNII:
W6KX9E6D8X
Molecule Type:
Small molecule
Molecular Formula:
CH4N2O
Molecular Weight:
61.05
AlogP:
-0.98
PSA:
69.11
HBD:
2.0
HBA:
#RotB:
0.0
Source:
SPARFLOXACIN
(1996)
Small molecule
Bacterial DNA gyrase inhibitor
ORAL
Approved
Bacterial Infections
SPARFLOXACIN
×
Maximum Phase:
4
First Approval:
1996
UNII:
Q90AGA787L
Molecule Type:
Small molecule
Molecular Formula:
C19H22F2N4O3
Molecular Weight:
392.41
AlogP:
2.08
PSA:
100.59
HBD:
3.0
HBA:
#RotB:
3.0
Source:
FOSFOMYCIN TROMETHAMINE
(1996)
Small molecule
UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
ORAL
Approved
Urinary Tract Infections
FOSFOMYCIN TROMETHAMINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
7FXW6U30GY
Molecule Type:
Small molecule
Molecular Formula:
C7H18NO7P
Molecular Weight:
259.19
AlogP:
-0.09
PSA:
70.06
HBD:
2.0
HBA:
#RotB:
1.0
Source:
SIMETHICONE
(1996)
Small molecule
Antifoaming agent
Unknown
Approved
Unknown
SIMETHICONE
×
Maximum Phase:
4
First Approval:
1996
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ROPIVACAINE HYDROCHLORIDE
(1996)
Small molecule
Sodium channel alpha subunit blocker
INJECTION
Approved
Acute Pain
ROPIVACAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
V910P86109
Molecule Type:
Small molecule
Molecular Formula:
C17H27ClN2O
Molecular Weight:
310.87
AlogP:
3.51
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
4.0
Source:
LEVOFLOXACIN
(1996)
Small molecule
DNA gyrase inhibitor
INJECTION; OPHTHALMIC; ORAL
Approved
Acne Vulgaris; Bacterial Infections; Bronchitis, Chronic; Conjunctivitis, Bacterial; Corneal Ulcer; Eye Infections; Infections; Otitis Externa; Pneumonia; Sinusitis; Urinary Tract Infections
LEVOFLOXACIN
×
Maximum Phase:
4
First Approval:
1996
UNII:
6GNT3Y5LMF
Molecule Type:
Small molecule
Molecular Formula:
C18H20FN3O4
Molecular Weight:
361.37
AlogP:
1.54
PSA:
75.01
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PENTOSAN POLYSULFATE SODIUM
(1996)
Small molecule
Unknown
ORAL
Approved
Unknown
PENTOSAN POLYSULFATE SODIUM
×
Maximum Phase:
4
First Approval:
1996
UNII:
914032762Y
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DONEPEZIL
(1996)
Small molecule
Unknown
Unknown
Approved
Dementia
DONEPEZIL
×
Maximum Phase:
4
First Approval:
1996
UNII:
8SSC91326P
Molecule Type:
Small molecule
Molecular Formula:
C24H29NO3
Molecular Weight:
379.5
AlogP:
4.36
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
6.0
Source:
TOPOTECAN HYDROCHLORIDE
(1996)
Small molecule
DNA topoisomerase I, mitochondrial inhibitor
INJECTION; INTRAVENOUS; ORAL
Approved
Carcinoma; Carcinoma, Ovarian Epithelial; Carcinoma, Small Cell; Ovarian Neoplasms; Small Cell Lung Carcinoma
TOPOTECAN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
956S425ZCY
Molecule Type:
Small molecule
Molecular Formula:
C23H24ClN3O5
Molecular Weight:
457.91
AlogP:
1.85
PSA:
104.89
HBD:
2.0
HBA:
#RotB:
3.0
Source:
VALSARTAN
(1996)
Small molecule
Type-1 angiotensin II receptor antagonist
ORAL
Approved
Cardiovascular Diseases; Diabetes Mellitus; Heart Failure; Hypertension; Myocardial Infarction; Stroke; Ventricular Dysfunction, Left
VALSARTAN
×
Maximum Phase:
4
First Approval:
1996
UNII:
80M03YXJ7I
Molecule Type:
Small molecule
Molecular Formula:
C24H29N5O3
Molecular Weight:
435.53
AlogP:
4.16
PSA:
112.07
HBD:
2.0
HBA:
#RotB:
10.0
Source:
BUTENAFINE
(1996)
Small molecule
Unknown
Unknown
Approved
Unknown
BUTENAFINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
91Y494NL0X
Molecule Type:
Small molecule
Molecular Formula:
C23H27N
Molecular Weight:
317.48
AlogP:
5.77
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
4.0
Source:
CABERGOLINE
(1996)
Small molecule
Dopamine D2 receptor agonist
ORAL
Approved
Parkinson Disease; Pituitary Neoplasms
CABERGOLINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
LL60K9J05T
Molecule Type:
Small molecule
Molecular Formula:
C26H37N5O2
Molecular Weight:
451.62
AlogP:
3.19
PSA:
71.68
HBD:
2.0
HBA:
#RotB:
8.0
Source:
FEXOFENADINE HYDROCHLORIDE
(1996)
Small molecule
Histamine H1 receptor antagonist
ORAL
Approved
Hypersensitivity; Rhinitis, Allergic, Seasonal; Urticaria
FEXOFENADINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
2S068B75ZU
Molecule Type:
Small molecule
Molecular Formula:
C32H40ClNO4
Molecular Weight:
538.13
AlogP:
5.51
PSA:
81.0
HBD:
3.0
HBA:
#RotB:
10.0
Source:
AMLEXANOX
(1996)
Small molecule
Phosphodiesterase 4 inhibitor
DENTAL; TOPICAL
Approved
Lung Diseases, Obstructive
AMLEXANOX
×
Maximum Phase:
4
First Approval:
1996
UNII:
BRL1C2459K
Molecule Type:
Small molecule
Molecular Formula:
C16H14N2O4
Molecular Weight:
298.3
AlogP:
2.75
PSA:
106.42
HBD:
2.0
HBA:
#RotB:
2.0
Source:
TIZANIDINE
(1996)
Small molecule
Unknown
Unknown
Approved
Unknown
TIZANIDINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
6AI06C00GW
Molecule Type:
Small molecule
Molecular Formula:
C9H8ClN5S
Molecular Weight:
253.72
AlogP:
1.72
PSA:
62.2
HBD:
2.0
HBA:
#RotB:
1.0
Source:
BRIMONIDINE TARTRATE
(1996)
Small molecule
Adrenergic receptor alpha-2 agonist
OPHTHALMIC; TOPICAL
Approved
Erythema; Glaucoma; Glaucoma, Open-Angle; Hypertension; Intraocular Pressure; Ocular Hypertension; Rosacea
BRIMONIDINE TARTRATE
×
Maximum Phase:
4
First Approval:
1996
UNII:
4S9CL2DY2H
Molecule Type:
Small molecule
Molecular Formula:
C15H16BrN5O6
Molecular Weight:
442.23
AlogP:
1.76
PSA:
62.2
HBD:
2.0
HBA:
#RotB:
1.0
Source:
MIDODRINE
(1996)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
MIDODRINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
6YE7PBM15H
Molecule Type:
Small molecule
Molecular Formula:
C12H18N2O4
Molecular Weight:
254.29
AlogP:
-0.19
PSA:
93.81
HBD:
3.0
HBA:
#RotB:
6.0
Source:
TIZANIDINE HYDROCHLORIDE
(1996)
Small molecule
Adrenergic receptor alpha-2 agonist
ORAL
Approved
Muscle Spasticity
TIZANIDINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
B53E3NMY5C
Molecule Type:
Small molecule
Molecular Formula:
C9H9Cl2N5S
Molecular Weight:
290.18
AlogP:
1.72
PSA:
62.2
HBD:
2.0
HBA:
#RotB:
1.0
Source:
IRINOTECAN HYDROCHLORIDE
(1996)
Small molecule
DNA topoisomerase I inhibitor
INJECTION; INTRAVENOUS
Approved
Adenocarcinoma; Carcinoma
IRINOTECAN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
042LAQ1IIS
Molecule Type:
Small molecule
Molecular Formula:
C33H45ClN4O9
Molecular Weight:
677.19
AlogP:
4.09
PSA:
114.2
HBD:
1.0
HBA:
#RotB:
4.0
Source:
DONEPEZIL HYDROCHLORIDE
(1996)
Small molecule
Acetylcholinesterase inhibitor
ORAL
Approved
Alzheimer Disease; Dementia
DONEPEZIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
3O2T2PJ89D
Molecule Type:
Small molecule
Molecular Formula:
C24H30ClNO3
Molecular Weight:
415.96
AlogP:
4.36
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
6.0
Source:
DILTIAZEM MALATE
(1996)
Small molecule
Voltage-gated L-type calcium channel blocker
ORAL
Approved
Unknown
DILTIAZEM MALATE
×
Maximum Phase:
4
First Approval:
1996
UNII:
14Y6444DRP
Molecule Type:
Small molecule
Molecular Formula:
C26H32N2O9S
Molecular Weight:
548.61
AlogP:
3.37
PSA:
59.08
HBD:
0.0
HBA:
#RotB:
6.0
Source:
FOSPHENYTOIN SODIUM
(1996)
Small molecule
Sodium channel alpha subunit blocker
INJECTION
Approved
Seizures
FOSPHENYTOIN SODIUM
×
Maximum Phase:
4
First Approval:
1996
UNII:
7VLR55452Z
Molecule Type:
Small molecule
Molecular Formula:
C16H13N2Na2O6P
Molecular Weight:
406.24
AlogP:
1.55
PSA:
116.17
HBD:
3.0
HBA:
#RotB:
5.0
Source:
AZELASTINE
(1996)
Small molecule
Unknown
Unknown
Approved
Eye Manifestations; Hypersensitivity; Nasal Obstruction
AZELASTINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
ZQI909440X
Molecule Type:
Small molecule
Molecular Formula:
C22H24ClN3O
Molecular Weight:
381.91
AlogP:
4.3
PSA:
38.13
HBD:
0.0
HBA:
#RotB:
3.0
Source:
NILUTAMIDE
(1996)
Small molecule
Androgen Receptor antagonist
ORAL
Approved
Neoplasms; Prostatic Neoplasms
NILUTAMIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
51G6I8B902
Molecule Type:
Small molecule
Molecular Formula:
C12H10F3N3O4
Molecular Weight:
317.22
AlogP:
2.45
PSA:
92.55
HBD:
1.0
HBA:
#RotB:
2.0
Source:
SODIUM PHENYLBUTYRATE
(1996)
Small molecule
Glutamine sequestering agent
Unknown
Approved
Hyperammonemia; Urea Cycle Disorders, Inborn
SODIUM PHENYLBUTYRATE
×
Maximum Phase:
4
First Approval:
1996
UNII:
NT6K61736T
Molecule Type:
Small molecule
Molecular Formula:
C10H11NaO2
Molecular Weight:
186.19
AlogP:
2.09
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ATORVASTATIN
(1996)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases; Coronary Artery Disease; Hypercholesterolemia
ATORVASTATIN
×
Maximum Phase:
4
First Approval:
1996
UNII:
A0JWA85V8F
Molecule Type:
Small molecule
Molecular Formula:
C33H35FN2O5
Molecular Weight:
558.65
AlogP:
6.31
PSA:
111.79
HBD:
4.0
HBA:
#RotB:
12.0
Source:
BUTENAFINE HYDROCHLORIDE
(1996)
Small molecule
Squalene monooxygenase inhibitor
TOPICAL
Approved
Tinea
BUTENAFINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
R8XA2029ZI
Molecule Type:
Small molecule
Molecular Formula:
C23H28ClN
Molecular Weight:
353.94
AlogP:
5.77
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
4.0
Source:
BETAINE
(1996)
Small molecule
Betaine-homocysteine S-methyltransferase substrate
ORAL
Approved
Depressive Disorder; Homocystinuria
BETAINE
×
Maximum Phase:
4
First Approval:
1996
UNII:
3SCV180C9W
Molecule Type:
Small molecule
Molecular Formula:
C5H12NO2+
Molecular Weight:
118.16
AlogP:
-0.22
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
2.0
Source:
ETOPOSIDE PHOSPHATE
(1996)
Small molecule
DNA topoisomerase II alpha inhibitor
INJECTION
Approved
Carcinoma, Small Cell; Lung Neoplasms; Neoplasms; Small Cell Lung Carcinoma
ETOPOSIDE PHOSPHATE
×
Maximum Phase:
4
First Approval:
1996
UNII:
528XYJ8L1N
Molecule Type:
Small molecule
Molecular Formula:
C29H33O16P
Molecular Weight:
668.54
AlogP:
1.1
PSA:
207.36
HBD:
4.0
HBA:
#RotB:
7.0
Source:
GEMCITABINE HYDROCHLORIDE
(1996)
Small molecule
DNA polymerase (alpha/delta/epsilon) inhibitor
INJECTION; INTRAVENOUS
Approved
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Ovarian Neoplasms; Pancreatic Neoplasms
GEMCITABINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1996
UNII:
U347PV74IL
Molecule Type:
Small molecule
Molecular Formula:
C9H12ClF2N3O4
Molecular Weight:
299.66
AlogP:
-1.29
PSA:
110.6
HBD:
3.0
HBA:
#RotB:
2.0
Source:
RITONAVIR
(1996)
Small molecule
Cytochrome P450 3A inhibitor
ORAL
Approved
HIV Infections; Hepatitis C; Hepatitis C, Chronic; Virus Diseases
RITONAVIR
×
Maximum Phase:
4
First Approval:
1996
UNII:
O3J8G9O825
Molecule Type:
Small molecule
Molecular Formula:
C37H48N6O5S2
Molecular Weight:
720.96
AlogP:
5.91
PSA:
145.78
HBD:
4.0
HBA:
#RotB:
17.0
Source:
ZILEUTON
(1996)
Small molecule
Arachidonate 5-lipoxygenase inhibitor
ORAL
Approved
Asthma
ZILEUTON
×
Maximum Phase:
4
First Approval:
1996
UNII:
V1L22WVE2S
Molecule Type:
Small molecule
Molecular Formula:
C11H12N2O2S
Molecular Weight:
236.3
AlogP:
2.73
PSA:
66.56
HBD:
2.0
HBA:
#RotB:
2.0
Source:
IRINOTECAN
(1996)
Small molecule
Unknown
Unknown
Approved
Neoplasms
IRINOTECAN
×
Maximum Phase:
4
First Approval:
1996
UNII:
7673326042
Molecule Type:
Small molecule
Molecular Formula:
C33H38N4O6
Molecular Weight:
586.69
AlogP:
4.09
PSA:
114.2
HBD:
1.0
HBA:
#RotB:
4.0
Source:
1
2
…
44
45
46
47
48
49
50
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA